Oscar Health, Inc. (NYSE:OSCR) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have earned an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $19.75.

A number of analysts have recently weighed in on OSCR shares. Piper Sandler restated an “overweight” rating and issued a $25.00 price objective on shares of Oscar Health in a research note on Wednesday, July 10th. Wells Fargo & Company increased their price objective on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Wednesday, June 12th. Baird R W upgraded shares of Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Robert W. Baird started coverage on shares of Oscar Health in a research note on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price for the company. Finally, The Goldman Sachs Group raised their price target on shares of Oscar Health from $16.00 to $21.00 and gave the stock a “neutral” rating in a research report on Thursday, May 9th.

Oscar Health Trading Up 3.3 %

Shares of NYSE:OSCR opened at $15.82 on Friday. Oscar Health has a 1 year low of $4.72 and a 1 year high of $23.44. The firm has a fifty day moving average price of $18.10 and a 200 day moving average price of $16.39. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $3.75 billion, a PE ratio of -39.55 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The company had revenue of $2.14 billion during the quarter, compared to the consensus estimate of $1.99 billion. During the same quarter in the prior year, the company posted ($0.18) EPS. The firm’s revenue was up 45.8% on a year-over-year basis. Analysts expect that Oscar Health will post -0.06 EPS for the current fiscal year.

Insider Activity

In related news, EVP Alessandrea C. Quane sold 25,550 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $497,203.00. Following the completion of the transaction, the executive vice president now owns 237,347 shares of the company’s stock, valued at $4,618,772.62. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Oscar Health news, insider Mario Schlosser sold 5,808 shares of Oscar Health stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $113,023.68. Following the completion of the transaction, the insider now directly owns 65,920 shares of the company’s stock, valued at $1,282,803.20. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Alessandrea C. Quane sold 25,550 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $497,203.00. Following the completion of the sale, the executive vice president now directly owns 237,347 shares in the company, valued at approximately $4,618,772.62. The disclosure for this sale can be found here. In the last three months, insiders have sold 81,655 shares of company stock worth $1,589,006. Corporate insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Oscar Health by 270.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 265,031 shares of the company’s stock valued at $2,425,000 after acquiring an additional 193,512 shares during the last quarter. National Bank of Canada FI acquired a new position in Oscar Health in the fourth quarter worth $1,071,000. Symmetry Peak Management LLC acquired a new position in Oscar Health in the fourth quarter worth $488,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Oscar Health during the first quarter worth $4,117,000. Finally, TD Asset Management Inc raised its holdings in shares of Oscar Health by 71.9% in the fourth quarter. TD Asset Management Inc now owns 195,600 shares of the company’s stock valued at $1,790,000 after buying an additional 81,800 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.